The latest closing stock price for Enfusion as of February 24, 2025 is 11.44.
An investor who bought $1,000 worth of Enfusion stock at the IPO in 2021 would have $-423 today, roughly 0 times their original investment - a -16.73% compound annual growth rate over 3 years.
The all-time high Enfusion stock closing price was 22.94 on November 12, 2021.
The Enfusion 52-week high stock price is 11.80, which is 3.1% above the current share price.
The Enfusion 52-week low stock price is 7.83, which is 31.6% below the current share price.
The average Enfusion stock price for the last 52 weeks is 9.38.
An investor who bought $1,000 worth of Enfusion stock at the IPO in 2021 would have $-423 today, roughly 0 times their original investment - a -16.73% compound annual growth rate over 3 years.
The all-time high Enfusion stock closing price was 22.94 on November 12, 2021.
The Enfusion 52-week high stock price is 11.80, which is 3.1% above the current share price.
The Enfusion 52-week low stock price is 7.83, which is 31.6% below the current share price.
The average Enfusion stock price for the last 52 weeks is 9.38.